Exploratory Phase II Study of KRP-203 -A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of KRP-203 in Patients with Crohn's Disease in Active Phase
Phase 2
- Conditions
- Crohn's Disease
- Registration Number
- JPRN-jRCT2080222062
- Lead Sponsor
- Kyorin Pharmaceutical Co.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients who were diagnosed with Crohn's disease according to diagnostic criteria, etc.
Exclusion Criteria
-Patients with a colostomy or ileostomy.
-Patients with a short gut syndrome or imflammatory bowel disease except Crohn's disease, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CDAI<br>The improvement of CDAI.
- Secondary Outcome Measures
Name Time Method Inflammation markers,etc.<br>CRP, etc.